In many sub-Saharan African countries, declines in child mortality combined with a slow decline in fertility have resulted in children and young adults comprising a large part of the overall population. This is known as the youth bulge. The youth bulge is not new. Younger ...

Accelerating HIV prevention to reduce new infections by 75% The United Nations General Assembly agreed in June 2016 that ending AIDS as a public health threat by 2030 requires a Fast-Track response, with three milestones to be reached by 2020: Reduce new HIV infections to fewer ...

Today’s decision-makers have to make tough investment choices. What is the right level of investment? What is a fair share for HIV prevention? Where resources should be directed? Who should benefit? What is working and what is not? Should we focus on a single solution, ...

This publication is an update of the 2005 guidelines for measuring national HIV prevalence in populationbased surveys of the UNAIDS/WHO Working Group on Global HIV/AIDS and STI Surveillance. These guidelines are written for public health surveillance and programme officers responsible for monitoring the HIV epidemic ...

In Asia and the Pacific, an estimated 4.9 million people were living with HIV in 2012.  Although the rate of new HIV infections has decreased over the last decade, there are still an estimated 353 000 new infections each year in the region. HIV treatment ...

With this update of the consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection, WHO, for the first time, recommends that all people living with HIV be provided with antiretroviral therapy (ART). This will bring us one step closer to ...

WHO guidelines on the use of antiretroviral (ARV) drugs for treating and preventing HIV infection provide a public health approach for scaling up HIV care and treatment programmes and focus on simplified, harmonized and effective antiretroviral therapy (ART) regimens for use in resource-limited settings. In ...

National HIV testing guidelines are critical to the success and expansion of HIV testing services. This report sought to analyse national HIV testing policies in WHO focal countries. The focus of this review was two-fold: 1) To determine whether national HIV testing policies permit lay providers and ...

Новое сводное руководство по вопросам профилактики, диагностики, лечения и ухода в связи с ВИЧ-инфекцией для ключевых групп населения объединяет все существующие руководящие указания Всемирной организации здравоохранения (ВОЗ), относящиеся к следующим пяти группам населения, которые имеют ключевое значение для действий по борьбе с ВИЧ. Эти группы следующие: ...

WHO guidelines on the use of antiretroviral (ARV) drugs for treating and preventing HIV infection provide a public health approach for scaling up HIV care and treatment programmes and focus on simplified, harmonized and effective antiretroviral therapy (ART) regimens for use in resource-limited settings. In ...

The 2013 ‘Consolidated guidelines on the use of antiretroviral (ARV) drugs for treating and preventing HIV infection’, released in July 2013, are the latest and most comprehensive of a series of important guidelines on antiretroviral therapy (ART) over the last decade from the World Health ...

With this update of the consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection, WHO, for the first time, recommends that all people living with HIV be provided with antiretroviral therapy (ART). This will bring us one step closer to ...

The second edition of the World Health Organization (WHO) consolidated guidelines on the use of antiretrovirals (ARVs) updates the 2013 edition following an extensive review of evidence undertaken in 2015. Experience from country programmes, consultations with communities and modelling of potential impact have informed the ...